Media Center

Washington, D.C. - Today, House Judiciary Committee Chairman Jerrold Nadler (D-NY) delivered the following opening statement, as prepared, during the markup of H.R. 3617, the Marijuana Opportunity Reinvestment and Expungement (MORE) Act of 2021:

"I am proud to have introduced H.R. 3617, the 'Marijuana Opportunity Reinvestment and Expungement Act,' or the 'MORE Act,' joined by my colleagues Representatives Barbara Lee, Earl Blumenauer, Nydia Velazquez, Sheila Jackson Lee, and Hakeem Jeffries, as well as many colleagues on this Committee who have signed on as cosponsors.

Washington, D.C. - Today, House Judiciary Committee Chairman Jerrold Nadler (D-NY) and Subcommittee on Courts, Intellectual Property, and the Internet Chairman Hank Johnson (D-GA) issued the following joint statement on the Wall Street Journal's report that over 100 federal judges failed to recuse themselves from lawsuits involving companies in which they or their family held a financial interest:

Washington, D.C. - Today, House Judiciary Committee Chairman Jerrold Nadler (D-NY) delivered the following opening statement, as prepared, during the markup of H.R. 5374, the Stopping Harmful Offers on Platforms by Screening Against Fakes in E-Commerce (SHOP SAFE) Act:

Washington, D.C. - Today, House Judiciary Committee Chairman Jerrold Nadler (D-NY) delivered the following opening statement, as prepared, during the markup of H.R. 2873, the Affordable Prescriptions for Patients Through Promoting Competition Act of 2021:

"H.R. 2873, the 'Affordable Prescriptions for Patients Through Promoting Competition Act of 2021' is bipartisan legislation introduced by Antitrust Subcommittee Chairman Cicilline and Ranking Member Ken Buck to end an anti-competitive practice known as product hopping.

Washington, D.C. - Today, House Judiciary Committee Chairman Jerrold Nadler (D-NY) delivered the following opening statement, as prepared, during the markup of H.R. 2883, the Stop Stalling Access to Affordable Medications Act:

"Today, one quarter of Americans report that it is difficult to afford their medicines. In fact, exorbitant medical bills are one of the major reasons Americans seek bankruptcy relief.

Washington, D.C. - Today, House Judiciary Committee Chairman Jerrold Nadler (D-NY) delivered the following opening statement, as prepared, during the markup of H.R. 2891, the Preserve Access to Affordable Generics and Biosimilars Act:

"H.R. 2891, the 'Preserve Access to Affordable Generics and Biosimilars Act,' is a bipartisan bill that I introduced along with Representative Ken Buck to prohibit anti-competitive settlements, also called pay-for-delay agreements, that block access to affordable prescription drugs.

Washington, D.C. - Today, House Judiciary Committee Chairman Jerrold Nadler (D-NY) delivered the following opening statement, as prepared, during a Subcommittee on Antitrust, Commercial, and Administrative Law hearing on "Reviving Competition, Part 4: 21st Century Antitrust Reforms and the American Worker:"

"Mr. Chairman, as well all know, America's economy has become highly concentrated in recent decades. A small number of firms dominate a variety of markets that Americans rely on, including pharmaceuticals, airlines, broadband, online platforms, and meatpacking.

Washington, D.C. - Today, the U.S. House of Representatives passed H.R. 1693, the EQUAL Act, bipartisan legislation that eliminates the unjust sentencing disparity between crack cocaine and powder cocaine offenses, by a vote of 361-66. The legislation was favorably reported out of the House Judiciary Committee on July 21st and sent to the full House for consideration.